Moderna shares rose more than 2% in early trading

Tiger Newspress2021-08-31

Moderna shares rose more than 2% in early trading.

  • A study examining the immune response of Moderna's COVID-19 vaccine to Pfizer /BioNTech's found that the former created more than twice as many antibodies as the latter.
  • The study, published in theJournal of the American Medical Association, examined 2,499 health care workers in Belgium inoculated with one of the two vaccines.
免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Shlee
    2021-09-01
    Shlee
    Nice
  • MetalGuru
    2021-09-01
    MetalGuru
    They also developing cures for cancer and there disease.. 
  • koolgal
    2021-09-01
    koolgal
    Moderna versus Pfizer -  Who do you think will win? 
    • Benly8: 
      Both will go Hand in Hand
    • koolgal: 
      Yes that is true.  We need both to fight Covid - 19!👍😉
  • ahoon
    2021-09-01
    ahoon
    👍
  • YBinvest
    2021-09-01
    YBinvest
    Good. Should invest in mRNA companies
  • TANY0051
    2021-09-01
    TANY0051
    Go go go
发表看法
38